Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

SELL
$13.31 - $19.86 $5,723 - $8,539
-430 Reduced 1.47%
28,733 $570,000
Q4 2022

Jan 11, 2023

BUY
$12.74 - $15.12 $11,797 - $14,001
926 Added 3.28%
29,163 $397,000
Q3 2022

Oct 20, 2022

SELL
$12.93 - $17.17 $33,824 - $44,916
-2,616 Reduced 8.48%
28,237 $391,000
Q2 2022

Jul 08, 2022

BUY
$13.53 - $23.34 $35,719 - $61,617
2,640 Added 9.36%
30,853 $443,000
Q1 2022

Apr 14, 2022

SELL
$16.14 - $22.6 $8,070 - $11,300
-500 Reduced 1.74%
28,213 $637,000
Q4 2021

Jan 12, 2022

SELL
$18.64 - $36.77 $10,904 - $21,510
-585 Reduced 2.0%
28,713 $539,000
Q3 2021

Oct 07, 2021

BUY
$32.83 - $43.0 $49,606 - $64,973
1,511 Added 5.44%
29,298 $961,000
Q2 2021

Jul 12, 2021

BUY
$34.41 - $44.03 $20,129 - $25,757
585 Added 2.15%
27,787 $1.19 Million
Q1 2021

Apr 09, 2021

SELL
$37.29 - $47.19 $150,278 - $190,175
-4,030 Reduced 12.9%
27,202 $1.04 Million
Q4 2020

Jan 08, 2021

SELL
$34.3 - $44.09 $201,409 - $258,896
-5,872 Reduced 15.83%
31,232 $1.37 Million
Q3 2020

Oct 05, 2020

BUY
$27.86 - $39.35 $106,703 - $150,710
3,830 Added 11.51%
37,104 $1.46 Million
Q2 2020

Jul 06, 2020

BUY
$30.3 - $42.55 $18,786 - $26,381
620 Added 1.9%
33,274 $1.05 Million
Q1 2020

Apr 06, 2020

BUY
$30.0 - $54.18 $182,250 - $329,143
6,075 Added 22.86%
32,654 $1.15 Million
Q4 2019

Jan 07, 2020

SELL
$42.29 - $52.2 $21,525 - $26,569
-509 Reduced 1.88%
26,579 $1.29 Million
Q3 2019

Oct 02, 2019

BUY
$42.06 - $51.64 $640,784 - $786,735
15,235 Added 128.53%
27,088 $1.29 Million
Q2 2019

Jul 23, 2019

BUY
$33.93 - $43.66 $4,003 - $5,151
118 Added 1.01%
11,853 $508,000
Q1 2019

Apr 09, 2019

BUY
$26.74 - $41.32 $313,793 - $484,890
11,735 New
11,735 $453,000

Others Institutions Holding CSII

About Cardiovascular Systems Inc


  • Ticker CSII
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 41,905,900
  • Description
  • Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...
More about CSII
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.